Té Vuong

M.D. Radiation Oncology


Dr Vuong received her M.D. from the Université de Montréal and continued her postgraduate training in radiation oncology at the University of Toronto and the Institut Gustave Roussy and Institut Curie in Paris, France. She was trained as an internist, medical oncologist and radiation oncologist and her main practice has been in radiation oncology since 1988.

She was awarded numerous research grants, from CIHR, NCIC, TransmedTech, Nucletron, Elekta, Icad, and Sanofi Aventis. She was awarded a CIHR Investigator salary grant for the development on innovative radiation technologies.

She is presently Professor at McGill University in the Department of Oncology.

Her research is focused on patient centered care for patients with GI cancer.
Building on the advantages of Magnetic Resonance Imaging, she introduced in 1997 the concept of endorectal treatment with high dose rate brachytherapy for rectal cancer.

She has organized 5 International research meetings in Montreal on the use and applications of this cutting edge treatment, co-chaired 5 international world conferences on organ preserving perspectives for patients with rectal cancer. She has participated in numerous international organ preservation meetings from 2005 to 2019 (FICARE, Multidisciplinary International rectal cancer society symposium), working  in close collaboration with world-leading surgeons, radiologists and radiation oncologists in colo-rectal research to explore better treatment modalities to improve patient outcomes and quality of life. She organized multiple training workshops in Montreal, Europe and Asia to foster the development of better treatment options for patients. Through her research program she has developed an international collaborative research network over the past 20 years.

As technology is evolving, her team is composed of dynamic clinicians, medical physicists, and basic sciences researchers and students, and is actively exploring innovative treatment avenues to improve patient care. Highly targeted, more effective treatments are being developed leading to the concept of endorectal mini-invasive adaptive radiation therapy (EMIART).

Initially meant as a pre-operative modality, endorectal brachytherapy has evolved into an alternative treatment option for patients medically unfit for standard surgery.

As our knowledge and experience with this modality has evolved, the concept is presently in the validation steps to be presented as a curative option for patients with rectal cancer.
The team’s mission is to develop new treatment avenues using new technologies (Artificial intelligence, Imaging, new treatment devices and equipment, treatment software) leading to less invasive procedures than the present treatment standard of care, hopefully resulting in better patient quality of life.

The aim of this website is to facilitate the exchange of information with researchers and patients and to promote better patient centered research.

Sorry, no publications matched your criteria.